Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 권기환 | * |
dc.date.accessioned | 2016-08-28T12:08:25Z | - |
dc.date.available | 2016-08-28T12:08:25Z | - |
dc.date.issued | 2009 | * |
dc.identifier.issn | 0896-4327 | * |
dc.identifier.other | OAK-5954 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/220281 | - |
dc.description.abstract | Background: There are still controversies about long-term clinical outcomes of sirolimus-eluting stents (SES) versus bare metal stents (BMS) implantation in patients with end-stage renal diseases (ESRD). Objective: To compare long-term outcomes in patients with (ESRD) following SES versus BMS implantation. Methods: Between March 2003 and July 2005, a total of 54 patients (80 lesions) with ESRD undergoing SES implantation [SES-ESRD] were enrolled and compared with 51 patients (54 lesions) with ESRD receiving BMS during the same periods [BMS-ESRD] in the Korean Multicenter Angioplasty Team Registry. The primary outcome was the composite of death, myocardial infarction (MI), or any stent thrombosis (ST) according to the Academic Research Consortium definition during a 3-year follow-up. Results: The cumulative 3-year rate of composite of death, MI, or ST of the SES-ESRD group (24%) was nearly similar with that of the BMS-ESRD group (24%, P = 1.000). The 3-year rates of death (26% vs. 24%, P = 0.824) or MACE (37% vs. 43%, P = 0.331) in the SES-ESRD did not differ significantly from those in the BMS-ESRD. However, the SES-ESRD showed a sustained lower 3-year TVR rate (9%), compared with BMS-ESRD (24%, P = 0.042). The rate of any ST in SES-ESRD was not significantly higher than that in the BMS-ESRD (17% vs. 14%, P = 0.788). There was no significant difference in the rate of late or very late ST between SES-ESRD (15%) versus BMS-ESRD group (10%, P = 0.557). Conclusions: SES did not increase the risks for death, MI, or any ST in patients with ESRD during the long-term follow-up, compared with BMS. (J Interven Cardiol 2009;22:411-419) © 2009, Wiley Periodicals, Inc. | * |
dc.language | English | * |
dc.title | Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: Results of Korean multicenter angioplasty team (KOMATE) registry: CORONARY ARTERY DISEASE | * |
dc.type | Article | * |
dc.relation.issue | 5 | * |
dc.relation.volume | 22 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 411 | * |
dc.relation.lastpage | 419 | * |
dc.relation.journaltitle | Journal of Interventional Cardiology | * |
dc.identifier.doi | 10.1111/j.1540-8183.2009.00495.x | * |
dc.identifier.wosid | WOS:000270588800001 | * |
dc.identifier.scopusid | 2-s2.0-70349741104 | * |
dc.author.google | Kim B.-K. | * |
dc.author.google | Oh S. | * |
dc.author.google | Jeon D.W. | * |
dc.author.google | Yang J.Y. | * |
dc.author.google | Kim J.-S. | * |
dc.author.google | Park S. | * |
dc.author.google | Choi D. | * |
dc.author.google | Jang Y. | * |
dc.author.google | Hong B.-K. | * |
dc.author.google | Kwon H.M. | * |
dc.author.google | Lee S.-W. | * |
dc.author.google | Goh C.W. | * |
dc.author.google | Kwon K. | * |
dc.author.google | Ryu S.K. | * |
dc.contributor.scopusid | 권기환(57203037966) | * |
dc.date.modifydate | 20240118164632 | * |